Molecular actions and clinical pharmacogenetics of lithium therapy
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Mood disorders, including bipolar disorder and depression, are relatively common human diseases for which pharmacological treatment options are often not optimal. Among existing pharmacological agents and mood stabilizers used for the treatment of mood disorders, lithium has a unique clinical profile. Lithium has efficacy in the treatment of bipolar disorder generally, and in particular mania, while also being useful in the adjunct treatment of refractory depression. In addition to antimanic and adjunct antidepressant efficacy, lithium is also proven effective in the reduction of suicide and suicidal behaviors. However, only a subset of patients manifests beneficial responses to lithium therapy and the underlying genetic factors of response are not exactly known. Here we discuss preclinical research suggesting mechanisms likely to underlie lithium’s therapeutic actions including direct targets inositol monophosphatase and glycogen synthase kinase-3 (GSK-3) among others, as well as indirect actions including modulation of neurotrophic and neurotransmitter systems and circadian function. We follow with a discussion of current knowledge related to the pharmacogenetic underpinnings of effective lithium therapy in patients within this context. Progress in elucidation of genetic factors that may be involved in human response to lithium pharmacology has been slow, and there is still limited conclusive evidence for the role of a particular genetic factor. However, the development of new approaches such as genome-wide association studies (GWAS), and increased use of genetic testing and improved identification of mood disorder patients sub-groups will lead to improved elucidation of relevant genetic factors in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888 · cited 1×
“This unique cyclic nature of bipolar disorder and the multiple disease states makes the negative impact even greater due to the high levels of disease burden and the financial costs associated with the treatment and management (Dilsaver, 2011; Murray et al., 2012).”
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 1×
“For example, the less common met variant is associated with changes in cognitive performance (Egan et al., 2003; Montag et al., 2010; Soliman et al., 2010).”
BackgroundMerikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) · BMJ · doi:10.1136/bmj.f3646 · Cited by 920 · cited 1×
“Metanalyses indicate superiority of lithium over other treatments in reducing mortality associated with suicide in patients with mood disorders (Cipriani et al., 2005; Baldessarini et al., 2006; Cipriani et al., 2013).”
BackgroundPezawas, L., Verchinski, B. A., Mattay, V. S., Callicott, J. H., Kolachana, B. S., Straub, R. E., Egan, M. F., Meyer-Lindenberg, A., & Weinberger, D. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2680-04.2004 · Cited by 890
Decreased risk of suicides and attempts during long‐term lithium treatment: a meta‐analytic review
Baldessarini, R. J., Tondo, L., Davis, P., Pompili, M., Goodwin, F. K., & Hennen, J. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00344.x · Cited by 753
Baum, A. E., Akula, N., Cabanero, M., Cardona, I., Corona, W., Klemens, B., Schulze, T. G., Cichon, S., Rietschel, M., Nöthen, M. M., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002012 · Cited by 700
Self-citationSleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation
Harvey, A. G. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08010098 · Cited by 601
A Genetic Variant BDNF Polymorphism Alters Extinction Learning in Both Mouse and Human
Soliman, F., Glatt, C. E., Bath, K. G., Levita, L., Jones, R. M., Pattwell, S. S., Jing, D., Tottenham, N., Amso, D., Somerville, L. H., et al. (2010) · Science · doi:10.1126/science.1181886 · Cited by 585 · cited 1×
“For example, the less common met variant is associated with changes in cognitive performance (Egan et al., 2003; Montag et al., 2010; Soliman et al., 2010).”
BackgroundHPA Axis Reactivity: A Mechanism Underlying the Associations Among 5-HTTLPR, Stress, and Depression
Gotlib, I. H., Joormann, J., Minor, K. L., & Hallmayer, J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.008 · Cited by 558
Toxicity of lithium to humans and the environment—A literature review
Aral, H., & Vecchio-Sadus, A. (2008) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2008.02.026 · Cited by 546 · cited 1×
“There are no known essential biological functions of lithium in the human body (Aral and Vecchio-Sadus, 2008).”
BackgroundIs Response to Prophylactic Lithium a Familial Trait?
Grof, P., Duffy, A., Cavazzoni, P., Grof, E., Garnham, J., MacDougall, M., O'Donovan, C., & Alda, M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1013 · Cited by 438 · cited 4×
“The accumulating evidence indicates that lithium-responsive bipolar disorder patients have a greater likelihood of having relatives with bipolar disorder (Mendlewicz et al., 1973), and a greater chance of having other lithium-responsive relatives (Grof et al., 2002).”
BackgroundMethodInfluentialZalsman, G., Huang, Y.-Y., Oquendo, M. A., Burke, A. K., Hu, X.-Z., Brent, D. A., Ellis, S. P., Goldman, D., & Mann, J. J. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1588 · Cited by 371 · cited 2×
“…been implicated in higher risk and severity of mood disorders, vulnerability to stressful life events and altered cortisol response to stress (Collier et al., 1996; Caspi et al., 2003; Kendler et al., 2005; Zalsman et al., 2006; Gotlib et al., 2008; Alexander et al., 2009; Mueller et al., 2011).”
BackgroundSmith, E. N., Bloss, C. S., Badner, J. A., Barrett, T., Belmonte, P. L., Berrettini, W., Byerley, W., Coryell, W., Craig, D., Edenberg, H. J., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.43 · Cited by 363 · cited 1×
“A genome-wide association study implicated a SNP in NTRK2 gene which codes for the TrkB receptor of the BDNF signaling cascade as a bipolar disorder risk factor, although this association did not reach genome-wide significance (Smith et al., 2009).”
BackgroundSelf-citationPrickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J. A., & Steckler, T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5216-05.2006 · Cited by 341 · cited 1×
“There is evidence suggesting that lithium’s effect on reducing the hyperlocomotion behavior induced by drugs that increase dopaminergic activity is related to direct actions on GSK-3 (Beaulieu et al., 2004; Prickaerts et al., 2006; Polter et al., 2010; Urs et al., 2012).”
BackgroundBenedetti, F., Serretti, A., Colombo, C., Barbini, B., Lorenzi, C., Campori, E., & Smeraldi, E. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20038 · Cited by 324 · cited 2×
“Among these polymorphisms, the 3111 T/C SNP in the CLOCK gene has been implicated in the bipolar disorder multiple times, and the C allele was associated with higher rates of recurrence of episodes, reduced sleep and insomnia among bipolar disorder patients (Benedetti et al., 2003; Serretti et al., 2003, 2005).”
BackgroundSuggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder
Nievergelt, C. M., Kripke, D. F., Barrett, T. B., Burg, E., Remick, R. A., Sadovnick, A. D., McElroy, S. L., Keck, P. E., Schork, N. J., & Kelsoe, J. R. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30252 · Cited by 294 · cited 3×
“In addition to the CLOCK gene, polymorphisms in other genes in the circadian clock system, such as PER3, ARNTL, TIMELESS, ARNTL2, DBP, VIP, and NR1D1 have been associated with the bipolar disorder (Mansour et al., 2006; Nievergelt et al., 2006; Benedetti et al., 2008; Shi et al., 2008; Soria et al., 2010) (for a revie…”
BackgroundResultMansour, H. A., Wood, J., Logue, T., Chowdari, K. V., Dayal, M., Kupfer, D. J., Monk, T. H., Devlin, B., & Nimgaonkar, V. L. (2006) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00147.x · Cited by 293
Serretti, A., Benedetti, F., Mandelli, L., Lorenzi, C., Pirovano, A., Colombo, C., & Smeraldi, E. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20053 · Cited by 264
Wu, J. C., Kelsoe, J. R., Schachat, C., Bunney, B. G., DeModena, A., Golshan, S., Gillin, J. C., Potkin, S. G., & Bunney, W. E. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.018 · Cited by 263 · cited 2×
“for example with sleep deprivation, has efficacy in the treatment of the depressive phase of bipolar disorder and can increase the likelihood of switching to the hypomanic phase (Colombo et al., 1999; Wu et al., 2009).”
BackgroundLazarus, J. H. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.002 · Cited by 230 · cited 1×
“…proper use may lead to severe consequences ranging from weight gain, renal failure, diabetes insipidus, thyroid enlargement (goiter) and hypothyroidism (Schou et al., 1968; Schou, 1984; Adityanjee and Thampy, 2005; Goodwin and Jamison, 2007; Lazarus, 2009; Rej et al., 2012; Werneke et al., 2012).”
BackgroundPolter, A., Beurel, E., Yang, S., Garner, R., Song, L., Miller, C. A., Sweatt, J. D., McMahon, L., Bartolucci, A. A., Li, X., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.43 · Cited by 225 · cited 1×
“There is evidence suggesting that lithium’s effect on reducing the hyperlocomotion behavior induced by drugs that increase dopaminergic activity is related to direct actions on GSK-3 (Beaulieu et al., 2004; Prickaerts et al., 2006; Polter et al., 2010; Urs et al., 2012).”
BackgroundGSK3B polymorphisms alter transcription and splicing in Parkinson's disease
Kwok, J. B. J., Hallupp, M., Loy, C. T., Chan, D. K. Y., Woo, J., Mellick, G. D., Buchanan, D. D., Silburn, P. A., Halliday, G. M., & Schofield, P. R. (2005) · Annals of Neurology · doi:10.1002/ana.20691 · Cited by 205 · cited 1×
“This SNP is functional and the T allele has higher transcriptional activity compared to the C allele (Kwok et al., 2005).”
BackgroundBenedetti, F., Serretti, A., Colombo, C., Lorenzi, C., Tubazio, V., & Smeraldi, E. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.050 · Cited by 195 · cited 1×
“…allele of this SNP have been shown to have a later onset of the disease compared to homozygous carriers of the common allele and homozygous rare allele carrier patients have been shown to manifest a better therapeutic response to total sleep deprivation treatment (Benedetti et al., 2004a, 2004b).”
BackgroundBenedetti, F., Serretti, A., Pontiggia, A., Bernasconi, A., Lorenzi, C., Colombo, C., & Smeraldi, E. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.022 · Cited by 184 · cited 2×
“Benedetti et al. (2005) GSK-3β, A1727T BD patients, mixed backgrounds mostly Caucasian (43M, 91F) No association with lithium response Michelon et al. (2006) GSK-3β, rs334558 BD patients (41M, 48F) No association with lithium response Szczepankiewicz et al. (2006) GSK-3β, rs334558 BD/unipolar…”
BackgroundAlexander, N., Kuepper, Y., Schmitz, A., Osinsky, R., Kozyra, E., & Hennig, J. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.03.017 · Cited by 171 · cited 2×
“…been implicated in higher risk and severity of mood disorders, vulnerability to stressful life events and altered cortisol response to stress (Collier et al., 1996; Caspi et al., 2003; Kendler et al., 2005; Zalsman et al., 2006; Gotlib et al., 2008; Alexander et al., 2009; Mueller et al., 2011).”
BackgroundInsomnia improvement during antidepressant treatment andCLOCK gene polymorphism
Serretti, A., Cusin, C., Benedetti, F., Mandelli, L., Pirovano, A., Zanardi, R., Colombo, C., & Smeraldi, E. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30130 · Cited by 164 · cited 1×
“…the 3111 T/C SNP in the CLOCK gene has been implicated in the bipolar disorder multiple times, and the C allele was associated with higher rates of recurrence of episodes, reduced sleep and insomnia among bipolar disorder patients (Benedetti et al., 2003; Serretti et al., 2003, 2005).”
BackgroundAngelucci, F., Aloe, L., Jiménez-Vasquez, P., & Mathé, A. A. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003468 · Cited by 157
Michelon, L., Meira-Lima, I., Cordeiro, Q., Miguita, K., Breen, G., Collier, D., & Vallada, H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.05.001 · Cited by 104
Lithium- and Valproate-Induced Alterations in Circadian Locomotor Behavior in Drosophila
Dokucu, M. E., Yu, L., & Taghert, P. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300764 · Cited by 96 · cited 1×
“Administration of lithium can extend the circadian period across a variety of species from Drosophila, rodents, non-human primates and humans (McEachron et al., 1981; Johnsson et al., 1983; Possidente and Exner, 1986; Welsh and Moore-Ede, 1990; Hafen and Wollnik, 1994; Dokucu et al., 2005).”
BackgroundLee, K. Y., Ahn, Y. M., Joo, E.-J., Jeong, S.-H., Chang, J. S., Kim, S.-C., & Kim, Y. S. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.059 · Cited by 54 · cited 2×
“P A A uthor M anuscript control, bipolar disorder and schizophrenia patients did not detect a significant association between the −50 T/C SNP and these psychiatric conditions (Lee et al., 2006).”
BackgroundLithium--Early Development, Toxicity, and Renal Function
Johnson, G. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00019-0 · Cited by 48
Cited by
Hou, L., Heilbronner, U., Degenhardt, F., Adli, M., Akiyama, K., Akula, N., Ardau, R., Arias, B., Backlund, L., Banzato, C. E. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00143-4 · Cited by 385
Self-citationConvergent Mechanisms Underlying Rapid Antidepressant Action
Zanos, P., Thompson, S. M., Duman, R. S., Zarate, C. A., & Gould, T. D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0492-x · Cited by 171
“not identical functions, has been extensively linked with the antidepressant actions of lithium [346, 347] and has been implicated in the rapid antidepressant actions of ketamine [51].”
BackgroundSelf-citationAnimal models of bipolar mania: The past, present and future
Logan, R. W., & McClung, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.041 · Cited by 136
Lithium in the treatment of major depressive disorder
Bschor, T. (2014) · Drugs · doi:10.1007/s40265-014-0220-x · Cited by 94
Rej, S., Elie, D., Mucsi, I., Looper, K. J., & Segal, M. (2015) · Drugs & Aging · doi:10.1007/s40266-014-0234-9 · Cited by 31
Metadata
- Authors
- Can, A., Schulze, T. G., & Gould, T. D.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 123
- Pages
- 3-16
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2025998453
- Cited by
- 120
- References
- 37
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.